Catalyst Wire Dossier Catalyst Wire Dossier

mTOR kinase inhibitor

· AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mTOR kinase inhibitor, covering 2011-05-16 to 2011-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours [Phase 1]

See pricing